Bicara Therapeutics Inc. (BCAX) Institutional Ownership and Insiders Activity
Bicara Therapeutics Inc. (BCAX) is widely held by institutional investors, with 163 firms reporting positions valued at approximately $1.94B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Ra Capital Management, L.P. is the largest disclosed holder, reporting approximately $215.43M in BCAX holdings in its latest filing.
Institutional Holders
163
Total Reported Value
$1.94B
Largest Holder
Ra Capital Management, L.P.
Largest Position
$215.43M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
40
Funds Exiting Positions
19
Top Institutional Owners
View allInvestorReported Balance
- Ra Capital Management, L.P.$215.43M
- T. Rowe Price Investment Management, Inc.$188.19M
- Siren, L.L.C.$166.35M
- Vestal Point Capital, Lp$155.87M
- Deep Track Capital, Lp$121.73M
Related BCAX Institutional Insights:
- BCAX 13F Institutional Holders
- BCAX Superinvestors
- BCAX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- BCAX Insider Trading & SEC Form 4 Activity
- BCAX Articles
- Top Institutional Investor Stock Rankings